Screening for Fear of Hypoglycemia in Type 1 Diabetes: Aligning Clinical Practice With Current Guidelines
Main finding · HbA1cResult — go to the resultAverage difference in HbA1c 0.48 % CI 0.12–0.83Authors' conclusion
As FOH remains under-assessed clinically, a validated one-item screening question can facilitate targeted and individualized clinical discussions for efficient recommendations and therapeutic adjustments.
Study context
- Population
- Adults living with T1D in an online registry; mean age 44.3 ± 15.1 years43% fear of hypoglycemia (FOH) +
- Participants
- 1,437 adults
- Exposure
- FOH+ vs others
- Outcome
- Association of the one-item FOH screening question with HbA1c and Hypoglycemia Fear Survey-II scores
Methodological detailsonline registry, self-reported data, regression models adjusted for gender, hypoglycemia history and hypoglycemia confidence
- Online registry
- Self-reported data
- Regression models adjusted for gender, hypoglycemia history and hypoglycemia confidence
Main finding
HbA1c
Average difference in HbA1c
0.48 %
CI 0.12–0.83
By group
FOH +
30%
FOH +
average difference in HbA1c 0.48 % (CI 0.12–0.83)
As reported in the abstract
Observational data: associations, not effects.
Further findings
| Outcome | Total score coefficient (CI) |
|---|---|
| Hypoglycemia Fear Survey-II total scoreSignificantly higher with FOH + | 11.0 (9.1–12.8) |
Characteristics of FOH +
- FOH + more likely to self-identify as women, use medication for depression or anxiety, and report lower hypoglycemia confidence
Original publication
Screening for Fear of Hypoglycemia in Type 1 Diabetes: Aligning Clinical Practice With Current Guidelines. Endocr Pract. Published 15 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →